EMA publishes Video explaining the new Pharmacovigilance Legislation
On the Road to 30,000 Members
Let us become the World's Leading GMP/GDP Compliance Community in 2026
The European Medicines Agency has produced a video with an introduction to the new pharmacovigilance legislation. Watch Dr Peter Arlett, Head of Pharmacovigilance and Risk Management, talking about the new and improved tools for regulators in Europe to ensure that patients are not exposed to unnecessary risks when taking medicines.
The new pharmacovigilance legislation came into operation on 2 July 2012. Its aim is to promote and protect public health by strengthening the existing Europe-wide system for monitoring the safety and benefit-risk balance of medicines.
Source and video
Related GMP News
21.10.2026EMA Clarifies ESMP Reporting for Critical Medicine Shortages
20.10.2026EDQM Updates Guidance on CEP Sister File Applications
20.10.2026EDQM Revises Guidance on Electronic Submissions for CEP Applications
14.10.2026Bioassays in the United States Pharmacopoeia - Two Chapters come into Force in Spring
07.10.2026CEP 2.0: EDQM Updates Guidance on the Use of Certificates of Suitability
23.09.2026IRIS Portal: EMA expands digital Procedure Management